EMERGENCE THERAPEUTICS

Emergence Therapeutics is a European biopharmaceutical company developing novel antibody drug conjugate (ADC) immuno-therapeutics to treat high need cancers. The lead program features innovative antibody design as well as state of the art linker and payload technology to target Nectin-4 – an important and validated target for a broad range of cancers.

Year of investment
2021

Sector
Drug development

Location
Duisburg, Germany

Website
http://emergencetx.com/

Leave a Reply

Your email address will not be published. Required fields are marked *